NRXS · Insider Trading
Neuraxis, Inc.
Every open-market purchase and sale reported by NRXS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-26 | Adrian Miranda | CMO, SVP Science & Tech | A | +199,106 | — |
| 2026-08-26 | Thomas Joeseph Carrico | CRO, CCO, CPO | A | +193,678 | — |
| 2026-08-26 | Brian Allen Carrico | Chief Executive Officer | A | +199,188 | — |
| 2026-08-17 | Bradley Mitchell Watkins | Director | A | +26,073 | +$163.74K |
| 2026-08-17 | Kristin A Ferge | Director | A | +31,134 | +$195.52K |
| 2026-08-17 | Adrian Miranda | CMO, SVP Science & Tech | A | +133,341 deriv. | — |
| 2026-08-17 | Thomas Joeseph Carrico | CRO, CCO, CPO | A | +135,906 deriv. | — |
| 2026-08-17 | Gil Aharon | Director | A | +86,224 | +$275.88K |
| 2026-08-17 | Jane Elizabeth Keyser | Director | A | +26,073 | +$163.74K |
| 2026-08-17 | Brian Allen Carrico | Chief Executive Officer | A | +193,329 deriv. | — |
| 2026-08-17 | Timothy Robert Henrichs | Chief Financial Officer | A | +141,479 deriv. | — |
| 2026-04-03 | Timothy Robert Henrichs | Chief Financial Officer | Buy | +7,593 | +$14.88K |
| 2026-04-03 | Brian Allen Carrico | Chief Executive Officer | Buy | +8,060 | +$15.80K |
| 2026-04-03 | Thomas Joeseph Carrico | CRO, CCO, CPO | Buy | +667 | +$1.31K |
| 2026-03-02 | Adrian Miranda | CMO, SVP Science & Tech | A | +47,569 deriv. | — |
| 2026-02-26 | Brian Allen Carrico | Chief Executive Officer | A | +94,173 deriv. | — |
| 2026-02-26 | Jane Elizabeth Keyser | Director | A | +21,598 | +$100.00K |
| 2026-02-26 | Bradley Mitchell Watkins | Director | A | +21,598 | +$100.00K |
| 2026-02-26 | Thomas Joeseph Carrico | CRO, CCO, CPO | A | +47,569 deriv. | — |
| 2026-02-26 | Timothy Robert Henrichs | Chief Financial Officer | A | +75,231 deriv. | — |
| 2026-02-13 | Brian Hannasch | 10%+ Owner | Buy | +80,000 | +$382.80K |
| 2026-01-30 | Gil Aharon | Director | A | +21,598 | +$100.00K |
| 2026-01-30 | Kristin A Ferge | Director | A | +21,598 | +$100.00K |
| 2025-12-29 | Gil Aharon | Director | Buy | +286,138 | +$1.01M |
| 2025-09-10 | Bradley Mitchell Watkins | Director | A | +13,157 | +$37.50K |
| 2025-09-10 | Kristin A Ferge | Director | A | +13,157 | +$37.50K |
| 2025-09-10 | Adrian Miranda | CMO, SVP Science & Tech | A | +75,000 deriv. | — |
| 2025-09-10 | Jane Elizabeth Keyser | Director | A | +13,157 | +$37.50K |
| 2025-09-10 | Thomas Joeseph Carrico | CRO, CCO, CPO | A | +72,435 deriv. | — |
| 2025-09-10 | Timothy Robert Henrichs | Chief Financial Officer | A | +242,017 deriv. | — |
| 2025-09-10 | Brian Allen Carrico | Chief Executive Officer | A | +170,659 deriv. | — |
| 2025-07-03 | Brian Hannasch | 10%+ Owner | Buy | +355,556 | +$800.00K |
| 2025-07-03 | MASIMO CORP | 10%+ Owner | MIXED | −531,548 | −$1.85M |
| 2025-04-23 | Brian Hannasch | 10%+ Owner | Buy | +18,065 | +$31.25K |
| 2024-07-02 | Jane Elizabeth Keyser | Director | A | +11,580 | — |
| 2024-07-02 | Bradley Mitchell Watkins | Director | A | +11,580 | — |
| 2024-07-02 | Kristin A Ferge | Director | A | +1,183 | — |
| 2024-02-29 | Brian Hannasch | 10%+ Owner | A | −75,000 | — |
| 2024-02-14 | Brian Hannasch | 10%+ Owner | J | −150,000 | — |
| 2024-01-23 | Brian Hannasch | 10%+ Owner | MIXED | +39,924 | +$2 |
| 2023-08-11 | MASIMO CORP | 10%+ Owner | C | +531,548 | — |
| 2023-08-10 | MASIMO CORP | 10%+ Owner | C | +531,548 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Brian Hannasch | 10%+ Owner | 1,171,522 | $8.33M |
| Gil Aharon | Director | 628,181 | $4.47M |
| MASIMO CORP | 10%+ Owner | 289,779 | $2.06M |
| Brian Allen Carrico | Chief Executive Officer | 227,336 | $1.62M |
| Thomas Joeseph Carrico | CRO, CCO, CPO | 199,345 | $1.42M |
| Adrian Miranda | CMO, SVP Science & Tech | 199,106 | $1.42M |
| Bradley Mitchell Watkins | Director | 72,408 | $514.82K |
| Jane Elizabeth Keyser | Director | 72,408 | $514.82K |
| Kristin A Ferge | Director | 67,072 | $476.88K |
| Timothy Robert Henrichs | Chief Financial Officer | 7,593 | $53.99K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NRXS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.